1. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
   Tatsuhiro Sato et al, 2018, International Journal of Molecular Sciences CrossRef
2. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin
   Kaushik Kuche et al, 2023, International Journal of Biological Macromolecules CrossRef
3. Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells
   Jai-Sing Yang et al, 2017, Oncology Reports CrossRef
4. Simvastatin increases temozolomide‐induced cell death by targeting the fusion of autophagosomes and lysosomes
   Shahla Shojaei et al, 2020, The FEBS Journal CrossRef
5. Temozolomide, Simvastatin and Acetylshikonin Combination Induces Mitochondrial-Dependent Apoptosis in GBM Cells, Which Is Regulated by Autophagy
   Sima Hajiahmadi et al, 2023, Biology CrossRef
6. High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes
   Huma Rizwan et al, 2020, Life Sciences CrossRef
7. Simvastatin enhances irinotecan-induced apoptosis in prostate cancer via inhibition of MCL-1
   Mohammad A.Y. Alqudah et al, 2018, Saudi Pharmaceutical Journal CrossRef
8. What can independent research for mesothelioma achieve to treat this orphan disease?
   Alice Guazzelli et al, 2019, Expert Opinion on Investigational Drugs CrossRef
9. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
   Ki-Eun Hwang et al, 2015, Oncotarget CrossRef
10. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy
    Kaushik Kuche et al, 2024, Biomaterials Advances CrossRef
11. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
    Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef
12. Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety Assessment
    Kaushik Kuche et al, 2023, AAPS PharmSciTech CrossRef
13. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
    Arnaud Boyer et al, 2018, European Respiratory Review CrossRef
14. RETRACTED: The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells
    Zuhier Awan et al, 2020, Pharmaceutics CrossRef
15. Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury
    Baowei Ji et al, 2023, Applied Biochemistry and Biotechnology CrossRef
16. Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin
    Rudra Pangeni et al, 2018, Pharmaceutics CrossRef
17. Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
    Hao Wu et al, 2022, Journal of Oncology CrossRef
18. Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p
    Fuliang Bai et al, 2019, Aging CrossRef
19. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells
    Javad Alizadeh et al, 2017, Scientific Reports CrossRef
20. Reactive oxygen species a double-edged sword for mesothelioma
    Serena Benedetti et al, 2015, Oncotarget CrossRef